Urological cancer, Malmö
11 – 20 of 531
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Toward Improved Prostate Cancer Screening : Insights from the Göteborg-2 Trial
(
- Contribution to journal › Letter
-
Mark
Impact of smoking status on engagement in remote symptom monitoring after oncologic surgery : Implications for symptom management and readmission rates
(
- Contribution to journal › Article
-
Mark
Intratumoral distribution and pharmacokinetics of the radiolabeled ICAM-1 targeting monoclonal antibody R6.5 in a prostate cancer mouse model
2025) In Nuklearmedizin(
- Contribution to journal › Article
-
Mark
Confirmatory Biopsy Outcomes in Patients with Grade Group 2 Prostate Cancer : Implications for Early Management
(
- Contribution to journal › Article
-
Mark
Human proteome distribution atlas for tissue-specific plasma proteome dynamics
(
- Contribution to journal › Article
-
Mark
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma
(
- Contribution to journal › Article
- 2024
-
Mark
A pilot study of an organised population‐based testing programme for prostate cancer
(
- Contribution to journal › Article
-
Mark
Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management : A PIONEER Analysis Based on Big Data
(
- Contribution to journal › Article
-
Mark
How a population-based cohort of men estimate lifetime risk of prostate cancer in a survey before entering a prostate cancer screening trial in Sweden?
(
- Contribution to journal › Article
-
Mark
Molecular Subtypes Are Associated With Clinical Benefit in Cisplatin-Treated Metastatic Urothelial Cancer Patients
(
- Contribution to journal › Article